| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $18K | -96.4% |
| Cost of Revenue | $95K | -90.8% |
| Gross Profit | -$77K | +85.6% |
| R&D Expense | $825K | -92.7% |
| SG&A Expense | $21.7M | +40.0% |
| Operating Income | -$22.7M | +52.1% |
| Net Income | -$23.7M | +40.9% |
| EPS (Basic) | -$1.88 | +97.4% |
| EPS (Diluted) | -$1.88 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.7M | -6.3% |
| Current Assets | $4.4M | +7.9% |
| Total Assets | $8.5M | -36.1% |
| Current Liabilities | $2.4M | -56.7% |
| Total Liabilities | $2.4M | -62.9% |
| Stockholders' Equity | $6.0M | -9.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.1M | +56.9% |
| Capital Expenditures | $1.9M | -15.7% |
| Investing Cash Flow | -$1.3M | +20.1% |
| Financing Cash Flow | $13.2M | -55.6% |
| Free Cash Flow | -$13.9M | +53.8% |
| +97.4% |